Form APP ORDR GUGGENHEIM STRATEGIC
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crescent Biopharma prices $125M public offering of shares and warrants
- Tailored Brands files for IPO, plans Nasdaq listing under MENW
- Zoetis agrees to acquire veterinary teleradiology platform VitalRADS
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
